An observational study in Infectious Disease, Cardiovascular Diseases and General Population, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Recruiting at 1 site in France. Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2026-07-10.
Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Observational
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France).
Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.
Overall, 2000 men and women will be recruited during two years for an extensive clinical examination including a microbiota, blood, hair and DNA collection, cognitive tests, autonomous nervous system assessment, spirometry, pulse wave velocity measurement, a carotid doppler echo tracking.
626 studies on the registry are indexed under Communicable Diseases; 128 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 200 across 228 observational studies indexed under Communicable Diseases.
Browse Communicable Diseases studies →Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 378 studies on the registry; 81 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult men and women ramdomly selected from the voter registration lists in La Réunion island
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Observational study of 2000 adult men and women from the general population who will benefit from a free extensive health check up in La Reunion
Diagnostic Test: Blood, DNA, feces, urine, hair and skin microbiota collection
See above
Also known as: Ewing test, Spirometry, EKG, cognitive, anxiety and depression tests, carotid ultrasound, pulse wave velocity measurement, ankle brachial index measurement
Prevalence of cardiometabolic diseases
Prevalence rates for diabetes, hypertension, obesity, dyslipidemia, smoking and subclinical atherosclerosis markers
Time frame: cross sectional (at inclusion)
Prevalence of infectious diseases
Seroprevalence rates for chikungunya, dengue, zika, covid19
Time frame: cross sectional (at inclusion)
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut National de la Santé Et de la Recherche Médicale, France →